Your success is our mission
We specialize in product development, commercialization, and grant development support for small businesses in biotech. With an 81% SUCCESS RATE on NIH SBIR and STTR grants and contracts, our team is adept at securing non-dilutive funding for innovative diagnostics, drugs, and devices.
Our Philosophy
Time is a limited resource, and we want our work to be transformative – not only for our clients and their products, but also for improving human health. With this in mind, we support clients whose products or services are groundbreaking, devoting our time and expertise to projects with the greatest potential impact on research effectiveness and human health.
Over $650M Secured
Since 2009, we have helped clients secure more than $650 million in SBIR/STTR and non-SBIR/STTR funding.
81% Success Rate
81% of the NIH SBIR and STTR grants and contracts we prepared for clients were funded on the first submission or a later resubmission.
5X the NIH Average
With our tailored guidance, clients receive NIH SBIR and STTR awards at a rate of 5 times MORE than the average applicant.
Our Services
We provide a variety of services that include grant writing, submission, pre-award negotiation, and administrative support for the following programs:
National Institutes of Health (NIH)
- SBIR/STTR Phase I, Phase II, Direct-to-Phase II, Phase IIB, and Commercial Readiness Program (CRP) grant applications
- SBIR/STTR Phase I and Phase II contract applications
- Non-SBIR/STTR contract applications
National Science Foundation (NSF)
- SBIR/STTR Project Pitches
- SBIR/STTR Phase I and Phase II grant applications
Other Federal Agencies
- Advanced Research Projects Agency for Health (ARPA-H)
- Congressionally Directed Medical Research Program (CDMRP)
- Department of Defense (DoD)
- Biomedical Advanced Research and Development Authority (BARDA)
Consulting and Administrative Support
We also offer a comprehensive consultation package for companies who want to better understand where their products or services could be most competitive for non-dilutive funding. This includes a review of your technology and available data, identification of relevant funding opportunities, a roadmap for submitting grant applications, advice on steps you can take to better position your projects for success, and more …
Testimonials
” I just finished reading the final draft of our application and all I can think is “wow.” From start to finish, the process felt manageable alongside the workload of running a rapidly growing business – not because it was easy but because it was so well led. The final product elevated our mission-driven work to exacting academic standards and made non-dilutive funding possible. Thank you! “
– Anne Wintemute
Co-Founder and CEO of Aimee Says, Inc.
” DeBusk & Fife is the only grant writing firm I recommend to other small businesses in biotech. I can’t say enough good things about the work they produce, and when it comes time to hand off grant writing at my own companies, DeBusk & Fife is the first and only team I (will) go to. “
– Rose Nash
CEO and Founder of Biota, Inc.
” As first-time founders, we were fortunate to connect with our ideal partner in DeBusk & Fife. Thanks to Julie and Bryan, we were able to submit our SBIR Phase I application in the first review cycle after our founding (within three months) and achieve a score that is turning heads! DeBusk & Fife helped us navigate a very complicated application process and make the right decisions at every point. What would have been overwhelming was reduced to routine. With so many challenges and unknowns to face as an entrepreneur, it is an incredible feeling to have confidence that you’ve made the right choice and you’re headed for the best outcome possible. The experience was so valuable and instructive to me as a founder that I have been recommending them highly to everyone in my network. Even experienced executives have been grateful for the connection. Partnering with them has been the best decision we have made as a team, and we are excited to continue the collaboration in every way possible moving forward. Do yourself a favor and contact them today! “
– Russ Ernst
Co-Founder and CEO of Motive Therapeutics, Inc.
For more testimonials, please click here
DeBusk & Fife 